Very Small and Soft Scorpionates: Water Stable Technetium
Tricarbonyl Complexes Combining a Bis-agostic (k3-H, H, S)
Binding Motif with Pendant and Integrated Bioactive
Molecules
posted on 2006-11-15, 00:00authored byLeonor Maria, António Paulo, Isabel C. Santos, Isabel Santos, Philipp Kurz, Bernhard Spingler, Roger Alberto
The novel trihydro(mercaptoazolyl)borates Na[H3B(timMe)] (L1) (timMe = 2-mercapto-1-methylimidazolyl), Na[H3B(timBupip)] (L2) (timBupip = 1-[4-((2-methoxyphenyl)-1-piperazinyl)butyl]-2-mercaptoimidazolyl),
and Na[H3B(bzt)] (L3) (bzt = 2-mercaptobenzothiazolyl) were synthesized by reaction of NaBH4 with the
corresponding azole. Ligands L1−L3 represent a new class of light and soft scorpionates that stabilizes
the [M(CO)3]+ core (M = 99Tc, Re) by formation of the complexes fac-[M{κ3-H(μ-H)2B(timMe)}(CO)3] (M =
99Tc (1), Re (2)), fac-[Re{κ3-H(μ-H)2B(timBupip)}(CO)3] (3), and fac-[Re{κ3-H(μ-H)2B(bzt)}(CO)3] (4),
respectively. The soft scorpionates are coordinated to the metal in unique (κ3-H, H‘, S) fashion, as confirmed
by X-ray crystallography of 1, 2, and 4. These complexes with bis-agostic hydride coordination are formed
in aqueous solution with the two hydrides replacing two coordinating aquo ligands. The agostic hydrogen
atoms were located directly, confirming an unprecedented donor atom set combining one sulfur and two
hydrogen atoms. Preliminary studies have shown the possibility of preparing some of these complexes at
the no carrier added level (99mTc), under conditions as required in radiopharmaceutical preparation. Due to
their lipophilicity, small-size, and easy functionalization with adequate biomolecules, the trihydro(mercaptoazolyl)borate technetium tricarbonyl complexes are suitable for the design of CNS receptor ligand
radiopharmaceuticals as exemplified with 3, comprising a pendant serotonergic 5-HT1A ligand. The integrated
design of radiopharmaceuticals involving a bis-agostic scorpionate ligand is demonstrated by the synthesis
of 4, with an integrated benzothiazolyl fragment for the recognition of β-amyloid plaques.